Search Results - "Wagner, Catriona A."

Refine Results
  1. 1

    The contribution of neutrophils to CNS autoimmunity by Pierson, Emily R, Wagner, Catriona A, Goverman, Joan M

    Published in Clinical immunology (Orlando, Fla.) (01-04-2018)
    “…Abstract Multiple sclerosis (MS) is believed to be initiated when myelin-specific T cells infiltrate the central nervous system (CNS), triggering subsequent…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Barcode‐Enabled Sequencing of Plasmablast Antibody Repertoires in Rheumatoid Arthritis by Tan, Yann‐Chong, Kongpachith, Sarah, Blum, Lisa K., Ju, Chia‐Hsin, Lahey, Lauren J., Lu, Daniel R., Cai, Xiaoyong, Wagner, Catriona A., Lindstrom, Tamsin M., Sokolove, Jeremy, Robinson, William H.

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-10-2014)
    “…Objective A hallmark of rheumatoid arthritis (RA) is the production of autoantibodies, including anti–citrullinated protein antibodies (ACPAs). Nevertheless,…”
    Get full text
    Journal Article
  5. 5

    Neutrophils isolated from systemic lupus erythematosus patients exhibit a distinct functional phenotype by Jog, Neelakshi R, Wagner, Catriona A, Aberle, Teresa, Chakravarty, Eliza F, Arriens, Cristina, Guthridge, Joel M, James, Judith A

    Published in Frontiers in immunology (2024)
    “…Neutrophil dysregulation, particularly of a low-density subset, is associated with systemic lupus erythematosus (SLE); however, the exact role of…”
    Get full text
    Journal Article
  6. 6

    Serum inflammatory mediators as markers of human Lyme disease activity by Soloski, Mark J, Crowder, Lauren A, Lahey, Lauren J, Wagner, Catriona A, Robinson, William H, Aucott, John N

    Published in PloS one (01-04-2014)
    “…Chemokines and cytokines are key signaling molecules that orchestrate the trafficking of immune cells, direct them to sites of tissue injury and inflammation…”
    Get full text
    Journal Article
  7. 7

    Genetic load in incomplete lupus erythematosus by Slief, Matt, Kheir, Joseph M, Smith, Miles, Mowery, Colin, Macwana, Susan, DeJager, Wade, Wagner, Catriona A, Aberle, Teresa, James, Judith A, Guthridge, Joel M

    Published in Lupus science & medicine (01-01-2023)
    “…Patients with incomplete lupus erythematosus (ILE) have lupus features but insufficient criteria for SLE classification. Some patients with ILE transition to…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The promise of precision medicine in rheumatology by Guthridge, Joel M., Wagner, Catriona A., James, Judith A.

    Published in Nature medicine (01-07-2022)
    “…Systemic autoimmune rheumatic diseases (SARDs) exhibit extensive heterogeneity in clinical presentation, disease course, and treatment response. Therefore,…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Novel Insights and Therapeutics in Multiple Sclerosis [version 1; peer review: 3 approved] by Wagner, Catriona A, Goverman, Joan M

    Published in F1000 research (2015)
    “…The last twelve years have witnessed the development of new therapies for relapsing-remitting multiple sclerosis that demonstrate increased efficacy relative…”
    Get full text
    Journal Article
  12. 12

    Pathogenic T cell cytokines in multiple sclerosis by Wagner, Catriona A, Roqué, Pamela J, Goverman, Joan M

    Published in The Journal of experimental medicine (06-01-2020)
    “…Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system that is believed to have an autoimmune etiology. As MS is the…”
    Get full text
    Journal Article
  13. 13

    Myelin-specific CD8+ T cells exacerbate brain inflammation in CNS autoimmunity by Wagner, Catriona A, Roqué, Pamela J, Mileur, Trevor R, Liggitt, Denny, Goverman, Joan M

    Published in The Journal of clinical investigation (02-01-2020)
    “…Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the CNS. Although CD4+ T cells are implicated in MS pathogenesis and have been the main…”
    Get full text
    Journal Article
  14. 14

    Cutting Edge: Integrin α4 Is Required for Regulatory B Cell Control of Experimental Autoimmune Encephalomyelitis by Glatigny, Simon, Wagner, Catriona A, Bettelli, Estelle

    Published in The Journal of immunology (1950) (01-05-2016)
    “…The neutralization of integrin α4 (Itga4) is currently used as treatment in multiple sclerosis. Although most studies have focused on its function on…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study by Aucott, John N, Soloski, Mark J, Rebman, Alison W, Crowder, Lauren A, Lahey, Lauren J, Wagner, Catriona A, Robinson, William H, Bechtold, Kathleen T

    Published in Clinical and vaccine immunology (01-09-2016)
    “…Approximately 10% to 20% of patients optimally treated for early Lyme disease develop persistent symptoms of unknown pathophysiology termed posttreatment Lyme…”
    Get full text
    Journal Article
  20. 20